History in perspective: How Alzheimer's Disease came to be where it is?
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
History in perspective: How Alzheimer's Disease came to be where it is?
Authors
Keywords
Neurodegenerative dementia, Alzheimer’s Disease, History, Diagnosis, Pathogenesis, Biomarkers
Journal
BRAIN RESEARCH
Volume 1758, Issue -, Pages 147342
Publisher
Elsevier BV
Online
2021-02-04
DOI
10.1016/j.brainres.2021.147342
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Amyloid-β in Alzheimer’s Disease: A Study of Citation Practices of the Amyloid Cascade Hypothesis Between 1992 and 2019
- (2020) Timothy Daly et al. JOURNAL OF ALZHEIMERS DISEASE
- The physiological roles of tau and Aβ: implications for Alzheimer’s disease pathology and therapeutics
- (2020) Sarah A. Kent et al. ACTA NEUROPATHOLOGICA
- Role of tau protein in Alzheimer's disease: The prime pathological player
- (2020) Shibi Muralidar et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- Oxford Brain Diagnostics: turning MRI into a diagnosis tool for dementia
- (2020) Simon Makin NATURE
- Synergy between amyloid-β and tau in Alzheimer’s disease
- (2020) Marc Aurel Busche et al. NATURE NEUROSCIENCE
- Associations of quantitative susceptibility mapping with Alzheimer's disease clinical and imaging markers
- (2020) Petrice M. Cogswell et al. NEUROIMAGE
- Advantages and disadvantages of the use of the CSF Amyloid β (Aβ) 42/40 ratio in the diagnosis of Alzheimer’s Disease
- (2019) Oskar Hansson et al. Alzheimers Research & Therapy
- Diagnosis of Alzheimer’s disease utilizing amyloid and tau as fluid biomarkers
- (2019) Jinny Claire Lee et al. EXPERIMENTAL AND MOLECULAR MEDICINE
- BACE1 inhibitors: Current status and future directions in treating Alzheimer's disease
- (2019) Nour M. Moussa‐Pacha et al. MEDICINAL RESEARCH REVIEWS
- FDG-PET as an independent biomarker for Alzheimer’s biological diagnosis: a longitudinal study
- (2019) Ya-Nan Ou et al. Alzheimers Research & Therapy
- Association of Extracellular Vesicle Biomarkers With Alzheimer Disease in the Baltimore Longitudinal Study of Aging
- (2019) Dimitrios Kapogiannis et al. JAMA Neurology
- Incremental value of amyloid-PET versus CSF in the diagnosis of Alzheimer’s disease
- (2019) Matteo Cotta Ramusino et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Cerebral amyloid angiopathy and Alzheimer disease — one peptide, two pathways
- (2019) Steven M. Greenberg et al. Nature Reviews Neurology
- Friend, Foe or Both? Immune Activity in Alzheimer’s Disease
- (2019) Georgia R. Frost et al. Frontiers in Aging Neuroscience
- NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease
- (2018) Clifford R. Jack et al. Alzheimers & Dementia
- Biomarkers for Alzheimer's disease: current status and prospects for the future
- (2018) K. Blennow et al. JOURNAL OF INTERNAL MEDICINE
- The heterogeneity within Alzheimer's disease
- (2018) Daniel Ferreira et al. Aging-US
- Molecular Pathogenesis of the Tauopathies
- (2018) Jürgen Götz et al. Annual Review of Pathology-Mechanisms of Disease
- Congo Red and amyloids: history and relationship
- (2018) Elmira I. Yakupova et al. BIOSCIENCE REPORTS
- Blood-based biomarkers for Alzheimer disease: mapping the road to the clinic
- (2018) Harald Hampel et al. Nature Reviews Neurology
- The Early Events That Initiate β-Amyloid Aggregation in Alzheimer’s Disease
- (2018) Xingyu Zhang et al. Frontiers in Aging Neuroscience
- Interpreting Biomarker Results in Individual Patients With Mild Cognitive Impairment in the Alzheimer’s Biomarkers in Daily Practice (ABIDE) Project
- (2017) Ingrid S. van Maurik et al. JAMA Neurology
- What is the evidence that tau pathology spreads through prion-like propagation?
- (2017) Amrit Mudher et al. Acta Neuropathologica Communications
- Cerebrospinal Fluid Tau Protein Levels and 18F-Fluorodeoxyglucose Positron Emission Tomography in the Differential Diagnosis of Alzheimer’s Disease
- (2017) Igor Yakushev et al. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
- Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria
- (2016) Bruno Dubois et al. Alzheimers & Dementia
- CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis
- (2016) Bob Olsson et al. LANCET NEUROLOGY
- A Brief History of Tau
- (2015) M. Goedert et al. CLINICAL CHEMISTRY
- The genetic landscape of Alzheimer disease: clinical implications and perspectives
- (2015) Caroline Van Cauwenberghe et al. GENETICS IN MEDICINE
- Advances in MRI biomarkers for the diagnosis of Alzheimer's disease
- (2014) Elizabeth G Kehoe et al. Biomarkers in Medicine
- Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria
- (2014) Bruno Dubois et al. LANCET NEUROLOGY
- Early detection of Alzheimer's disease using PiB and FDG PET
- (2014) Ann D. Cohen et al. NEUROBIOLOGY OF DISEASE
- Imaging as a biomarker in drug discovery for Alzheimer’s disease: is MRI a suitable technology?
- (2014) Emilio Merlo Pich et al. Alzheimers Research & Therapy
- Fluorine-18 Radiolabeled Heterocycles as PET Tracers for Imaging β - Amyloid Plaques in Alzheimer’s Disease
- (2013) Fanxing Zeng et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Revised NIA-AA criteria for the diagnosis of Alzheimer's disease: a step forward but not yet ready for widespread clinical use
- (2011) Giovanni B. Frisoni et al. INTERNATIONAL PSYCHOGERIATRICS
- Diagnosis-Independent Alzheimer Disease Biomarker Signature in Cognitively Normal Elderly People
- (2010) Geert De Meyer ARCHIVES OF NEUROLOGY
- The clinical use of structural MRI in Alzheimer disease
- (2010) Giovanni B. Frisoni et al. Nature Reviews Neurology
- Alzheimer and his disease: a brief history
- (2010) Gabriele Cipriani et al. NEUROLOGICAL SCIENCES
- Propagation of Tau Misfolding from the Outside to the Inside of a Cell
- (2009) Bess Frost et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The future of amyloid-beta imaging: a tale of radionuclides and tracer proliferation
- (2008) William E Klunk et al. CURRENT OPINION IN NEUROLOGY
- Imaging amyloid deposition in Lewy body diseases
- (2008) S. N. Gomperts et al. NEUROLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started